Bharat Rasayan Ltd has informed BSE about : <BR><BR>1. Standalone Financial Results for the period ended December 31, 2025<BR><BR>2. Consolidated Financial Results for the period ended ....

Ebitda Margin ExpansionExceptional ItemResults RestatedResults View source PDF Explain this filing

BHARATRAS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.1%Reaction day

₹1752.50

prior close

₹1687.90

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.5%-3.7% vs market

Pesticides & Agrochemicals peers, median of 27sector-1.5%-3.6% vs sector

On the reaction day the stock moved 3.7 pts less than Nifty Microcap 250 and 3.6 pts less than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.1

10m

+0.8

15m

+1.4

30m

+0.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.1-1.5-3.7-1.5-3.6

Next day

-3.2-2.2-1.0-2.9-0.2

-3.0-1.2-1.8-1.9-1.1

-5.3-0.9-4.3-2.0-3.3

-7.0-2.3-4.7-3.8-3.3

-9.3-2.5-6.8-3.8-5.5

-10.1-3.6-6.5-6.8-3.3

15d

-23.3-10.4-12.9-10.6-12.7

-26.6-11.3-15.3-14.2-12.4

-9.8-3.6-6.3-7.8-2.0

-20.4+3.9-24.3-3.6-16.8

UpDownMarket · Nifty Microcap 250Sector · Pesticides & Agrochemicals peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Bharat Rasayan reported Q3 FY26 standalone revenue from operations of ₹270.46 crore, up ~5.5% from ₹256.40 crore in Q3 FY25. Nine-month revenue grew ~7.8% to ₹933.82 crore. Standalone Q3 PAT rose ~14.5% YoY to ₹33.99 crore, while 9M PAT grew ~7.4% to ₹103.81 crore. Operating margin expanded to 17.25% in Q3 (vs 16.63%) and 16.85% for 9M (vs 15.74%), supported by lower raw material costs. Consolidated Q3 PAT was higher at ₹40.03 crore (boosted by ₹6.04 crore share of joint venture profit), though 9M consolidated PAT declined ~7% YoY to ₹107.57 crore due to exceptional items. The company also completed a 1:1 bonus issue and share split (₹10 to ₹5 face value) during the quarter, restating EPS for prior periods.

Likely market impact

Margin expansion and steady revenue growth are positive signals, though the presence of exceptional items worth ₹13.29 crore in 9M FY26 (linked to Dahej plant insurance matters) dragged consolidated bottom-line growth. Credit rating reaffirmed at CARE AA-/A1+ and very low debt-equity (0.07x) suggest a stable financial profile for shareholders.